Diabetes Research and Clinical Practice
Volume 74, Issue 2, Supplement , Pages S63-S69, 30 November 2006

Therapy targeting β-cell survival and function in type 2 diabetes mellitus

US Exploratory Medicine, Eli Lilly and Co., Global External Research and Development, Building 75-C, Lilly Corporate Center, Indianapolis, IN, USA

published online 10 August 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0168-8227(06)00283-X

doi:10.1016/j.diabres.2006.06.014

Diabetes Research and Clinical Practice
Volume 74, Issue 2, Supplement , Pages S63-S69, 30 November 2006

Article Tools

* Image Usage & Resolution